PATENT CLAIM ANALYSIS

Application Number: 16007509
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-02
Patent Classification: ["424", "702000"]

Abstract:
A nutritional supplement containing fish oil and selenium has been identified that potentiates radiotherapy of tumors in a synergistic fashion. Cotherapy with such a supplement and radiotherapy results in substantially improved reductions in tumor volume of animal models relative to radiotherapy alone, and reduces common side effects such as weight loss, inflammation, and damage to the gastrointestinal tract. Such cotherapy was also found to reduce the incidence of metastasis from the primary implantation site, and to modulate expression of genes associated with apoptosis in tumor cells. A formulation for such a supplement that is both well tolerated and palatable is also provided.

Claim (Index 63):
The method of  claim 62 , wherein the nutritional supplement is provided to the patient prior to initiation of the radiotherapy protocol.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 94.0
- Lexical Diversity: 1.48649
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10172399', '11044638', '13348026', '13063589', '13348024']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6251229060066321
- 35 USC 102 Novelty (BERT): 0.5194602519675655
- Combined Prediction Score: 0.6145566406027254
- Mean Citation Score: 203.677466
- Max Citation Score: 220.88077
- Similarity Product: 125.61967641626714

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test